Central Nervous System (CNS) therapeutics Market Research Reports
Title | published | price | |
---|---|---|---|
Autism (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... />
Autism, also known as complex developmental disability, is a neurodevelopment disorder characterized by social interaction, verbal and nonverbal communication and repetitive behaviors. Risk factors include child's sex, family history, fragi......" | 31-Mar-2021 | $2000 | |
Cerebral Palsy (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... pipeline landscape.
Cerebral palsy is a group of disorders that can involve brain and nervous system functions, such as movement, learning, hearing, seeing, and thinking. Symptoms include muscles that are very tight and do not stretch, ......" | 31-Mar-2021 | $2000 | |
Cognitive Impairment Associated With Schizophrenia (CIAS) (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... ment, 2021, provides an overview of the Cognitive Impairment Associated With Schizophrenia (Central Nervous System) pipeline landscape.
Cognitive functioning is moderately to severely impair in patients with schizophrenia. Symptoms inclu......" | 31-Mar-2021 | $2000 | |
Fatigue (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... br />
Fatigue also referred to as tiredness, exhaustion, lethargy, listlessness, and describes a physical and/or mental state of being tired and weak. Signs and symptoms include aching or sore muscles, painful lymph nodes, chronic (long-term) ......" | 31-Mar-2021 | $2000 | |
Restless Legs Syndrome (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... (Central Nervous System) pipeline landscape.
Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), is a disorder of the part of the nervous system that affects the legs and causes an urge to move them. Symptoms include ......" | 31-Mar-2021 | $2000 | |
Sedation (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... e.
Sedation is the depression of irritability or agitation. Symptoms include talk slowly and may slur their speech, unable to concentrate, feel dizzy, slow breathing, heart rate, blood pressure will be lower. Treatment includes barbitura......" | 31-Mar-2021 | $2000 | |
Fibromyalgia (Fibromyalgia Syndrome) (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... al Nervous System) pipeline landscape.
Fibromyalgia is a disorder characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory and mood issues. Symptoms include fatigue, depression, headaches, and pain or crampi......" | 31-Mar-2021 | $2000 | |
Post-Operative Pain (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... Nervous System) pipeline landscape.
Pain is one of the main postoperative adverse outcomes causing distress to patients. Degree of postoperative pain experienced by individuals varies. Cause of pain includes peripheral nerve damage durin......" | 31-Mar-2021 | $2500 | |
Alcohol Addiction (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... s System) pipeline landscape.
Alcohol addiction refers to a psychological and physical dependency on alcohol. Symptoms include decreased involvement in extracurricular activities, depression, restlessness, inability to control drinking a......" | 31-Mar-2021 | $2500 | |
Obsessive-Compulsive Disorder (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... -Compulsive Disorder (Central Nervous System) pipeline landscape.
Obsessive-compulsive disorder (OCD) is characterized by unreasonable thoughts and fears (obsessions) that lead to do repetitive behaviors (compulsions). Symptoms include h......" | 31-Mar-2021 | $2000 | |
|